Sumitomo Chemical India Ltd
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]
- Market Cap ₹ 26,699 Cr.
- Current Price ₹ 535
- High / Low ₹ 665 / 363
- Stock P/E 48.2
- Book Value ₹ 67.8
- Dividend Yield 0.24 %
- ROCE 23.5 %
- ROE 17.6 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 34.5%
Cons
- Stock is trading at 7.89 times its book value
- The company has delivered a poor sales growth of 3.81% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 671 | 724 | 799 | 1,911 | 2,223 | 2,423 | 2,643 | 3,060 | 3,511 | 2,833 | 3,090 | 3,186 | |
| 614 | 635 | 698 | 1,691 | 1,932 | 2,088 | 2,155 | 2,458 | 2,843 | 2,358 | 2,467 | 2,520 | |
| Operating Profit | 57 | 89 | 101 | 219 | 291 | 335 | 488 | 603 | 668 | 474 | 623 | 666 |
| OPM % | 8% | 12% | 13% | 11% | 13% | 14% | 18% | 20% | 19% | 17% | 20% | 21% |
| 8 | 26 | 10 | 31 | -0 | -20 | 19 | 36 | 45 | 96 | 119 | 131 | |
| Interest | 1 | 1 | 1 | 5 | 5 | 7 | 7 | 8 | 6 | 5 | 6 | 7 |
| Depreciation | 6 | 7 | 7 | 24 | 28 | 41 | 47 | 45 | 52 | 61 | 63 | 63 |
| Profit before tax | 58 | 107 | 103 | 221 | 258 | 267 | 453 | 586 | 655 | 503 | 674 | 727 |
| Tax % | 40% | 40% | 40% | 34% | 35% | 23% | 24% | 26% | 23% | 27% | 26% | 25% |
| 35 | 65 | 62 | 145 | 167 | 206 | 345 | 434 | 503 | 370 | 502 | 543 | |
| EPS in Rs | 4.12 | 6.92 | 8.69 | 10.09 | 7.41 | 10.06 | 10.88 | |||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 38% | 18% | 12% | 12% | 12% | 80% | 12% | 12% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 4% |
| 3 Years: | -3% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 10% |
| 3 Years: | 3% |
| TTM: | 10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 9% |
| 1 Year: | -1% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 20% |
| 3 Years: | 17% |
| Last Year: | 18% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 233 | 233 | 275 | 275 | 275 | 499 | 499 | 499 | 499 | 499 | 499 | 499 |
| Reserves | -2 | 63 | 360 | 665 | 761 | 710 | 1,029 | 1,425 | 1,881 | 1,941 | 2,397 | 2,885 |
| 0 | 0 | 0 | 10 | 20 | 36 | 33 | 38 | 34 | 25 | 45 | 53 | |
| 234 | 280 | 288 | 695 | 791 | 848 | 1,097 | 1,047 | 955 | 822 | 988 | 997 | |
| Total Liabilities | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,368 | 3,287 | 3,930 | 4,434 |
| 51 | 52 | 53 | 267 | 279 | 319 | 309 | 390 | 430 | 489 | 482 | 499 | |
| CWIP | 0 | 1 | 7 | 9 | 8 | 10 | 14 | 35 | 71 | 23 | 28 | 20 |
| Investments | 0 | 0 | 277 | 2 | 1 | 87 | 291 | 357 | 239 | 425 | 601 | 1,226 |
| 415 | 523 | 585 | 1,367 | 1,558 | 1,676 | 2,043 | 2,227 | 2,628 | 2,351 | 2,819 | 2,690 | |
| Total Assets | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,368 | 3,287 | 3,930 | 4,434 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 52 | -21 | 49 | 75 | 222 | 424 | 223 | 389 | 756 | 458 | 443 | |
| -8 | -5 | -289 | -40 | -35 | -118 | -282 | -281 | -327 | -426 | -405 | -329 | |
| 0 | -0 | 276 | 7 | -65 | -61 | -47 | -63 | -73 | -331 | -65 | -81 | |
| Net Cash Flow | -4 | 47 | -34 | 16 | -26 | 43 | 95 | -120 | -10 | -1 | -11 | 33 |
| Free Cash Flow | -6 | 44 | -310 | 6 | 36 | 184 | 382 | 111 | 270 | 695 | 431 | 404 |
| CFO/OP | 44% | 102% | 14% | 60% | 56% | 90% | 109% | 61% | 83% | 187% | 100% | 91% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 83 | 92 | 101 | 105 | 110 | 128 | 117 | 101 | 98 | 91 | 90 | 81 |
| Inventory Days | 135 | 169 | 191 | 202 | 193 | 133 | 185 | 198 | 157 | 135 | 154 | 166 |
| Days Payable | 109 | 132 | 115 | 176 | 136 | 112 | 145 | 110 | 87 | 96 | 107 | 86 |
| Cash Conversion Cycle | 109 | 130 | 177 | 131 | 167 | 150 | 157 | 189 | 168 | 131 | 136 | 161 |
| Working Capital Days | 69 | 79 | 113 | 113 | 116 | 109 | 95 | 127 | 136 | 173 | 183 | 155 |
| ROCE % | 27% | 41% | 22% | 29% | 27% | 26% | 33% | 34% | 30% | 21% | 25% | 23% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Branded Products Revenue Share % |
|
||||||
| Domestic Revenue Share % |
|||||||
| Herbicides Revenue Share % |
|||||||
| Insecticides Revenue Share % |
|||||||
| Number of Distributors count |
|||||||
| Speciality Products Revenue Share % |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Certificate Under Regulation 74(5) Of SEBI( Depositories Participants) Regulations, 2015.
2h - Compliance certificate for quarter ended 30 June 2026 on dematerialised securities.
-
Board Meeting Intimation for Board Meeting Intimation For Intimation Of Schedule Of Board Meeting To Be Held On Monday, The 27Th July, 2026.
9 Jul - Board meeting on 27 July 2026 to consider Q1 FY27 standalone and consolidated results.
-
Reg. 34 (1) Annual Report.
3 Jul - FY26 annual report filed; PAT ₹543 crore, dividend ₹1.30/share, AGM on 27 July 2026, leadership transition proposed.
- Notice Of 26Th Annual General Meeting Of The Company To Be Held On 27Th July, 2026. 3 Jul
-
Reg. 34 (1) Annual Report.
2 Jul - FY26 annual report: revenue ₹3,238 crore, PAT ₹543 crore, dividend ₹1.30; AGM on 27 July 2026.
Annual reports
Concalls
-
Jun 2026Transcript PPT
-
Jan 2026TranscriptAI SummaryPPT
-
Jan 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT REC
-
Aug 2025TranscriptAI SummaryPPT
-
Jun 2025Transcript PPT
-
Jan 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
-
Jul 2024TranscriptAI SummaryPPT
-
Jun 2024Transcript PPT
-
Feb 2024TranscriptAI SummaryPPT
-
Nov 2023Transcript PPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptAI SummaryPPT
-
Aug 2022TranscriptAI SummaryPPT
-
Jun 2022Transcript PPT REC
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021Transcript PPT
-
Aug 2021TranscriptAI SummaryPPT
-
Jun 2021Transcript PPT
-
Feb 2021TranscriptAI SummaryPPT
-
Nov 2020Transcript PPT
-
Aug 2020TranscriptAI SummaryPPT
-
Jun 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
Products
The company operates in agorchemicals, including insecticides, weedicides, fungicides, fumigants, rodenticides, plant growth nutrition products, bio-rationals, and plant growth regulators. It markets proprietary products from its Japanese parent, Sumitomo Chemical Co., in agrochemicals, animal nutrition, and environmental health.[1]
The products comprise conventional chemistry sourced from SCC, and biological products sourced from a USA-based subsidiary, Valent Biosciences LLC. [2]